The Biology and Genetics of the IRF2BP2 Gene
At a Glance
IRF2BP2 deficiency is a genetic immune disorder caused by a change in one copy of the IRF2BP2 gene. It can disrupt immune signaling, prevent B cells from maturing normally, and lower antibody production, creating a CVID-like pattern with symptoms that vary widely among relatives.
To understand IRF2BP2-related immunodeficiency, it helps to think of your immune system as a complex security system. In most people, this system has two main parts: a “shield” that blocks infections and a “dimmer switch” that keeps the alarm from getting too loud. In people with this genetic condition, the shield is weak, and the dimmer switch is broken [1][2]. Keep in mind that much of our understanding of this specific biology comes from laboratory models, rather than routine clinical measurements.
The Role of the IRF2BP2 Protein in Research
The IRF2BP2 gene provides instructions for making a protein that lives in the nucleus of your immune cells (B cells and T cells). This protein acts as a transcriptional corepressor—a molecular “off switch” that tells other genes to stop working once their job is done [3].
Normally, when your immune system encounters a germ, it activates a pathway called NFAT (Nuclear Factor of Activated T-cells). This pathway acts like a megaphone, shouting for the body to produce TNF-alpha, a powerful chemical that causes inflammation to fight the germ. In laboratory experiments, the IRF2BP2 protein steps in to quiet the NFAT “megaphone” once the threat is gone. Research suggests that without enough working IRF2BP2, the megaphone stays on, leading to higher levels of TNF-alpha transcripts [1][4]. This does not mean that every patient has high circulating TNF-alpha in their blood, nor does it automatically select an anti-TNF drug for treatment.
Why Antibodies Are Low: The B-Cell Connection
The second job of IRF2BP2 involves helping B cells grow up. B cells are the cells that produce antibodies to protect you from future infections.
- B-Cell Maturation: To work correctly, B cells must mature into plasmablasts, which are the specialized cells that actually pump out antibodies. In patients with this condition, B cells often get “stuck” in an early stage and fail to become plasmablasts [5][4].
- Calcium Flux: For a B cell to receive the signal to grow and fight, it must move calcium inside the cell (a process called calcium signaling or flux). Research shows that IRF2BP2-deficient B cells have an impaired calcium signal, which prevents them from responding properly [1][4]. (Note: Calcium flux testing is a specialized research tool, not a routine clinical lab).
How the Condition is Inherited
This condition follows an autosomal dominant pattern of inheritance. This means you only need one mutated copy of the gene (from either parent) to potentially have the disease [2]. In some cases, the mutation is de novo, meaning it happened for the first time in the patient and was not inherited from a parent [2][4].
However, the disease also shows incomplete penetrance. This is a genetic term meaning that not everyone who carries the mutation will show the same symptoms. One family member might have severe lung and gut issues, while another with the exact same mutation might only have mild allergies or even no symptoms at all [1][2]. A genetics professional should guide testing to determine recurrence risk.
Types of Genetic Changes
Genetic testing usually identifies a specific “break” in the IRF2BP2 gene. Common types found in patients include:
- Nonsense and Frameshift mutations: These act like a “stop sign” in the middle of a sentence, preventing the cell from making the full protein (e.g., the p.Q540* variant) [4][2].
- Whole-gene deletions: A large piece of DNA containing the entire gene is missing [2].
- Haploinsufficiency: Because one of the two copies of the gene is broken, the body has impaired “off switch” protein activity [2][6].
How This Differs from Other Genes
While IRF2BP2 looks similar to other genetic causes of Common Variable Immunodeficiency (CVID), the “broken” biological pathway is different. For example:
- NFKB1 and NFKB2: These genes are linked to impaired p50 transcriptional activity or defective processing, affecting different parts of the immune system’s signaling [7][8].
- IRF2BP2: This primarily affects the NFAT pathway and calcium flux, making it a unique condition requiring specialized interpretation [1].
Common questions in this guide
What is IRF2BP2-related immunodeficiency?
How does an IRF2BP2 variant affect antibody production?
Can IRF2BP2-related immunodeficiency be inherited?
What do nonsense, frameshift, and whole-gene deletion variants mean?
Does IRF2BP2 deficiency always cause high TNF-alpha levels?
Should relatives who feel healthy be tested for an IRF2BP2 variant?
Get notified when new evidence is published on Common variable immunodeficiency phenotype due to IRF2BP2 deficiency.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (8)
- 1
IRF2BP2 deficiency: An important form of common variable immunodeficiency with inflammation.
Udemgba C, Pillay B, Shafer S, et al.
The Journal of allergy and clinical immunology 2025; (155(6)):2052-2062.e5 doi:10.1016/j.jaci.2025.02.038.
PMID: 40090425 - 2
Novel frameshift variants expand the map of the genetic defects in IRF2BP2.
García-Aznar JM, Maneiro Pampín E, García Ramos M, et al.
Frontiers in immunology 2023; (14()):1279171 doi:10.3389/fimmu.2023.1279171.
PMID: 37876937 - 3
IRF2BP2: A new player in the regulation of cell homeostasis.
Ramalho-Oliveira R, Oliveira-Vieira B, Viola JPB
Journal of leukocyte biology 2019; (106(3)):717-723 doi:10.1002/JLB.MR1218-507R.
PMID: 31022319 - 4
Novel mutation and expanding phenotype in IRF2BP2 deficiency.
Körholz J, Gabrielyan A, Sczakiel HL, et al.
Rheumatology (Oxford, England) 2023; (62(4)):1699-1705 doi:10.1093/rheumatology/keac575.
PMID: 36193988 - 5
Mutation in IRF2BP2 is responsible for a familial form of common variable immunodeficiency disorder.
Keller MD, Pandey R, Li D, et al.
The Journal of allergy and clinical immunology 2016; (138(2)):544-550.e4.
PMID: 27016798 - 6
Loss-of-function nuclear factor κB subunit 1 (NFKB1) variants are the most common monogenic cause of common variable immunodeficiency in Europeans.
Tuijnenburg P, Lango Allen H, Burns SO, et al.
The Journal of allergy and clinical immunology 2018; (142(4)):1285-1296 doi:10.1016/j.jaci.2018.01.039.
PMID: 29477724 - 7
Biochemically deleterious human NFKB1 variants underlie an autosomal dominant form of common variable immunodeficiency.
Li J, Lei WT, Zhang P, et al.
The Journal of experimental medicine 2021; (218(11)) doi:10.1084/jem.20210566.
PMID: 34473196 - 8
Intrinsic functional defects in B cells of patients with NFKB2 mutations.
Min Q, Li Y, Wu X, et al.
Clinical and experimental immunology 2025; (219(1)) doi:10.1093/cei/uxae090.
PMID: 39405181
This page is for informational purposes only and does not constitute medical advice. An immunologist or genetics professional should interpret your IRF2BP2 result and guide decisions about family testing.